Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38,512,859
-
Total 13F shares
-
24,542,560
-
Share change
-
-524,029
-
Total reported value
-
$25,524,580
-
Price per share
-
$1.04
-
Number of holders
-
33
-
Value change
-
-$666,577
-
Number of buys
-
10
-
Number of sells
-
16
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q3 2023
As of 30 Sep 2023,
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,542,560 shares.
The largest 10 holders included
Vivo Capital, LLC, TANG CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, Sofinnova Investments, Inc., Pivotal bioVenture Partners Investment Advisor LLC, ORBIMED ADVISORS LLC, Nan Fung Group Holdings Ltd, Samsara BioCapital, LLC, Newtyn Management, LLC, and VANGUARD GROUP INC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.